Suchergebnisse - "Amiot, Aurélien"

PubPharm (20)

1

Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

enthalten in: Alimentary pharmacology & therapeutics | 2024

von García, M. | Riestra, S. | Amiot, A. | +24

2

Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease : Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies

enthalten in: Journal of Crohn's & colitis | 2024

von Ten Bokkel Huinink, S. | Thomassen, D. | Steyerberg, E. | +17

3

Biologic Therapy for Budesonide-refractory, -dependent or -intolerant Microscopic Colitis : a Multicentre Cohort Study from the GETAID

enthalten in: Journal of Crohn's & colitis | 2022

von Boivineau, G. | Zallot, C. | Zerbib, F. | +6

4

Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease : Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Pauwels, R. | van der Woude, C. | Nieboer, D. | +55

CommentIn: Clin Gastroenterol Hepatol. 2022 Aug;20(8):1668-1670. - PMID 34058414

5

Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis : A GETAID cohort

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Uzzan, M. | Bresteau, C. | Laharie, D. | +49

CommentIn: Aliment Pharmacol Ther. 2021 Aug;54(3):341-342. - PMID 34236096

6

Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2021

von Laharie, D. | Bourreille, A. | Branche, J. | +26

7

Outcomes after double switching from originator Infliximab to biosimilar CT-P13 and biosimilar SB2 in patients with inflammatory bowel disease : a 12-month prospective cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Trystram, N. | Abitbol, V. | Tannoury, J. | +8

CommentIn: Aliment Pharmacol Ther. 2021 May;53(9):1038-1039. - PMID 33831242

8

Letter : immunogenicity of infliximab-ready for routine prediction?

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Amiot, A.

CommentOn: Aliment Pharmacol Ther. 2020 Feb;51(3):356-363. - PMID 31650614

9

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Bouguen, G. | Huguet, A. | Amiot, A. | +9

10

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Pineton de Chambrun, G. | Amiot, A. | Bouguen, G. | +33